News
After a second Elevidys patient death from acute liver failure, Sarepta in July launched a major restructuring that involves ...
Sarepta Therapeutics (SRPT) stock in focus as report says company hired a Trump-linked lobbying firm after deaths linked to ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported ...
Shares of Sarepta Therapeutics ( NASDAQ: SRPT) rose on Wednesday after the market as it reported second quarter revenue and ...
2d
GlobalData on MSNHansa’s Idefirix shows potential as pre-treatment to ElevidysHansa Biosciences’ Idefirix (imlifidase) has reduced patients’ antibodies to a level that allows dosing in patients with ...
Sarepta Therapeutics hired a Trump-connected lobbying firm after the death of a teenage boy treated with its Duchenne ...
The FDA is allowing Sarepta to resume shipments of Elevidys (delandistrogene moxeparvovec) to ambulatory patients with Duchenne muscular dystrophy.
22h
The New Republic on MSNLaura Loomer Is Getting a Taste of Her Own MedicineAs Laura Loomer wields a terrifying amount of power, other far-right influencers are accusing her of being a “plant.” ...
Novartis has made a takeover approach for rare disease-focused biotech Avidity Biosciences, as Big Pharma continues to hunt ...
Sarepta and Capricor learned of key regulatory decisions from the media and investors, and Duchenne muscular dystrophy ...
7hOpinion
The New Republic on MSNPete Hegseth Unveils Return of Pro-Slavery MonumentU.S. Defense Secretary Pete Hegseth announced Tuesday that a Confederate memorial would be reinstalled in Arlington Cemetery ...
10hOpinion
The New Republic on MSNIs Trump About to Drag Joe Rogan Into the Epstein Files Debacle?The Trump administration has been in a tailspin over the case files since the beginning of July, when the Justice Department ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results